Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Endocrine-exocrine Functions and Prognosis After Pancreatectomy
A recruiting clinical trial at National Taiwan University Hospital is investigating how pancreatectomy affects endocrine and exocrine pancre…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Support Through Remote Observation and Nutrition Guidance (STRONG) Program for Pancreatic Cancer Patients [NA]
Clinical trial update for the STRONG program, which supports pancreatic cancer patients with remote observation and nutrition guidance; the …
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Remote Exercise and Nutritional Prehabilitation for Pancreatic Cancer [NA]
A clinical trial (NCT06423963) is evaluating remote exercise and nutritional prehabilitation for pancreatic cancer and is currently recruiti…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Interrogation of Exosome-mediated Intercellular Signaling in Patients With Pancreatic Cancer
Clinical trial evaluating exosome-mediated intercellular signaling in patients with pancreatic cancer; currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Evaluating Obesity-Mediated Mechanisms of Pancreatic Carcinogenesis in Minority Populations
This trial aims to study obesity-related mechanisms that may drive pancreatic cancer development in minority populations. It is currently re…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: Pegcetacoplan in Combination With Modified FOLFIRINOX for the Treatment of Metastatic Pancreatic Ductal Adenocarcinoma [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating pegcetacoplan in combination with modified FOLFIRINOX for metastatic pancreatic ductal adenocarcinoma …
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: Clinical Study of CBG131 CAR-T Cell Injection for the Treatment of CLDN18.2-Positive Advanced Gastric and Pancreatic Cancer [EARLY_Phase 1]
An early-phase study evaluating CBG131 CAR-T cell therapy targeting CLDN18.2 for advanced gastric and pancreatic cancer. The trial is not ye…
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: Nal-IRI/5-FU/LV Chemotherapy Combined With PD-L1 Inhibitor and Multi-target Anti-angiogenic Small Molecule±SBRT as Second-line Therapy in Metastatic Pancreatic Cancer Patients [Phase 2]
This document reports a Phase 2 clinical trial evaluating nanoliposomal irinotecan (Nal-IRI) with 5-FU and leucovorin, combined with a PD-L1…
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: B-GLUCANCER2 : A Pilot Study Evaluating a New Method for Cancer Detection by Measuring the Activity of Different Glycosidase Enzymes in the Plasma of Patients With a Localized Cancer. [EARLY_Phase 1]
An early-phase clinical trial update for B-GLUCANCER2, a pilot study that assesses a blood-based detection method by measuring glycosidase e…
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: Study of Perioperative NP137 and FOLFIRINOX in Resectable Pancreatic Cancer [Phase 1]
Phase 1 clinical trial update evaluating perioperative NP137 in combination with FOLFIRINOX for resectable pancreatic cancer; the study is c…
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: Lipidomics, Proteomics, Micro RNAs and Volatile Organic Compounds (VOC)
This clinical trial update describes an ongoing multi-omics study in pancreatic neoplasms (lipidomics, proteomics, microRNAs, and volatile o…
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: Mainstreaming Genetics: Evaluation of a Digital Application to Scale and Spread Oncologist-initiated Genetic Testing [NA]
This clinical trial update describes evaluating a digital application designed to scale oncologist-initiated genetic testing across multiple…
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors [Phase 1]
Clinical trial update for RMC-5127 in KRAS G12V-mutant advanced solid tumors shows Phase 1 recruitment ongoing across non-small cell lung ca…
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: Nimotuzumab Combined With Chemoradiotherapy in the Treatment of Unresectable Locally Advanced or Oligometastatic Pancreatic Cancer [Phase 2]
Phase 2 clinical trial evaluating nimotuzumab in combination with chemoradiotherapy for unresectable locally advanced or oligometastatic pan…
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: Rectus Sheath Block With Liposomal Bupivacaine Versus Thoracic Epidural Analgesia for Pain Control Following Pancreatoduodenectomy [Phase 2]
Phase 2 clinical trial comparing rectus sheath block with liposomal bupivacaine versus thoracic epidural analgesia for pain control after pa…
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: Delayed Gastric Emptying After Pancreatic Surgery
A study sponsored by National Taiwan University Hospital is recruiting to study delayed gastric emptying after pancreatic surgery in patient…
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: Blood Markers of Early Pancreas Cancer
A University of Nebraska study is recruiting to identify blood biomarkers for early detection of pancreatic cancer.
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: An Artificial Intelligence System for Multimodal, Multi-class Diagnosing Solid Pancreatic Lesions Based on Endoscopic Ultrasound
A clinical trial update describes an AI system that uses multimodal data to diagnose solid pancreatic lesions from endoscopic ultrasound, wi…
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: The Effect of Kinisoquin™ on Thromboembolic Events in Patients With Metastatic or Locally Advanced Pancreatic Cancer [Phase 3]
Phase 3 trial investigating Kinisoquin™ for reducing thromboembolic events in patients with metastatic or locally advanced pancreatic cancer…
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: Olaparib and ASTX727 in BRCA1/2- and Homologous Recombination Deficient (HRD)-Mutated Tumors [Phase 1]
Phase 1 clinical trial update indicates a study of Olaparib in combination with ASTX727 for BRCA1/2- and homologous recombination deficiency…
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: Phase 1/2 Study TROP2 CAREngineered Cord Blood-Derived NK Cells + Belzutifan In Pancreatic Cancer [Phase 1, Phase 2]
This clinical trial update describes a phase 1/2 study of TROP2 CAR-engineered cord blood-derived NK cells in combination with belzutifan fo…
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of WEF-001 as Monotherapy in Advanced KRAS-Mutant Solid Tumours. [Phase 1, Phase 2]
Phase 1/2a trial evaluating WEF-001 as monotherapy for safety, tolerability, pharmacokinetics, and preliminary efficacy in advanced KRAS-mut…
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: SHARON: A Clinical Trial for Metastatic Cancer Using Chemotherapy and Patients' Own Stem Cells [Phase 1]
Phase 1 SHARON trial evaluating chemotherapy plus autologous stem cell transplantation for metastatic cancers; recruitment is ongoing.
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: Span-C-SBRT for Pancreatic Cancer [NA]
Clinical trial update for Span-C-SBRT for pancreatic cancer; the study on high-risk localized pancreatic cancer is currently active but not …
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: A First-in-Human Study of FID-022 in Solid Tumor Patients
A first-in-human study of the experimental agent FID-022 in solid tumors is listed, with pancreatic cancer and cancer cachexia as conditions…